Report overview
The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes. This helps in better pricing and rapid time to market for the otherwise unviable products in the short run. A higher adoption of combination approaches is expected to boost the global market for oral controlled release drug delivery technology.
This report contains market size and forecasts of Oral Controlled Release Drug Delivery Technology in Global, including the following market information:
Global Oral Controlled Release Drug Delivery Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oral Controlled Release Drug Delivery Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diffusion Controlled Release System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Controlled Release Drug Delivery Technology include AstraZeneca, Bristol-Myers Squibb, Sun Pharmaceuticals, Abbott, Merck, Novartis, Pfizer, Mylan and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Controlled Release Drug Delivery Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Controlled Release Drug Delivery Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oral Controlled Release Drug Delivery Technology Market Segment Percentages, by Type, 2021 (%)
Diffusion Controlled Release System
Dissolution Controlled Release System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Others
Global Oral Controlled Release Drug Delivery Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oral Controlled Release Drug Delivery Technology Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Medical
Others
Global Oral Controlled Release Drug Delivery Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oral Controlled Release Drug Delivery Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Controlled Release Drug Delivery Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oral Controlled Release Drug Delivery Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Bristol-Myers Squibb
Sun Pharmaceuticals
Abbott
Merck
Novartis
Pfizer
Mylan
Sanofi
